Intuitive Launches $100 Million Venture Capital Fund
October 27 2020 - 8:00AM
Intuitive (Nasdaq: ISRG), a global technology leader in minimally
invasive care and the pioneer of robotic-assisted surgery, today
announced the launch of Intuitive Ventures. The inaugural $100
million fund will invest in the future leaders of minimally
invasive care.
Intuitive Ventures is focused on investment opportunities in
digital tools, precision diagnostics, focal therapeutics and
platform technologies that share Intuitive’s commitment to
advancing positive outcomes in healthcare. The fund will support
independent initiatives in the direct and adjacent fields of
minimally invasive care and marks the entrance into the venture
capital space for parent company Intuitive.
“The future of minimally invasive care spans the patient journey
from early diagnosis to treatment and beyond,” said Julian
Nikolchev, President of Intuitive Ventures. ”Intuitive Ventures is
investing in cutting-edge innovation across the continuum of care
to bring the future forward.”
Nikolchev brings a deep entrepreneurial and operational
background with more than 30 years of experience in the development
and commercialization of therapeutic medical devices, including
leading early stage teams and technologies through growth and
market transformation. He joined Intuitive Surgical in 2019 and
will continue to serve as its Senior Vice President of Corporate
Development and Strategy.
Nikolchev is joined by Intuitive Ventures Director Dr. Oliver
Keown MD, who joined Intuitive in 2019 to co-found the fund. Keown
was previously an investor at GE Ventures where he drove
international deal-flow and supported digital and MedTech portfolio
companies operationally and at the board level. He also advised
U.K., U.S. and global healthcare innovation projects across
commercial, government, and academic fields.
“We are value-add investors who leverage access to Intuitive’s
unique industry expertise and customer connections,” Keown said.
“Our nimble structure and alignment with the startups we will back
empower us to invest early and support our portfolio companies as
they pioneer markets.’’
About Intuitive Ventures
Leveraging Intuitive’s entrepreneurial spirit and expansive
technological and clinical reach, Intuitive Ventures invests in
transformative opportunities advancing positive outcomes in
healthcare. The fund is focused on U.S. and international early
stage start-ups and takes a long-term outlook to support portfolio
companies reach their major milestones. Through its inaugural $100
million fund and with leadership combining decades of investing and
operational experience, the team cultivates strategic resources to
drive financial returns and accelerate the future of minimally
invasive care. Intuitive Ventures has already started deploying
capital and is actively building its portfolio. More information
and future updates can be found at: ventures.intuitive.com
About Intuitive
Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale,
Calif., is a global technology leader in minimally invasive care
and the pioneer of robotic-assisted surgery. As part of our
mission, we believe that minimally invasive care is life-enhancing
care. Through ingenuity and intelligent technology, we expand the
potential of physicians to heal without constraints.
Intuitive brings more than two decades of leadership in
robotic-assisted surgical technology and solutions to its
offerings, and develops, manufactures and markets the
da Vinci® surgical system and the Ion™ endoluminal
system.
For more information, please visit the company’s website
at www.intuitive.com.
Forward-Looking Statements
This press release contains forward-looking statements about
Intuitive Ventures and its plans to invest in early-stage
companies, including their potential benefits, that involves
substantial risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. Risks and uncertainties include, among other things,
the uncertainties inherent in research and development;
uncertainties regarding the ability of Intuitive Ventures to
identify investment candidates; uncertainties regarding the success
of Intuitive Ventures’ investments; uncertainties and variables
inherent in the operating and financial performance in investments
made, including, among other things, competitive developments and
general economic, political, business, industry, regulatory and
market conditions; future exchange and interest rates; and changes
in tax and other laws, regulations, rates and policies. The Company
undertakes no obligation to publicly update or release any
revisions to these forward-looking statements, except as required
by law.
ContactGlobal Public AffairsIntuitive
Surgicalcorp.comm@intusurg.com+1-408-523-7337
Source: Intuitive Surgical, Inc.
Intuitive Surgical (NASDAQ:ISRG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intuitive Surgical (NASDAQ:ISRG)
Historical Stock Chart
From Apr 2023 to Apr 2024